Large numbers of men could have missed a prostate cancer diagnosis due to Covid-19. Combine that with a rise in prostate cancer and the future looks grim. Ultimately, something in the prostate cancer diagnostic landscape needs to change: but what? The post Changing the Prostate Cancer Screening Landscape appeared first on MedCity News.
In this second of a two-part article, we’ll cover common obstacles and offer insights on how to overcome these barriers to achieve success in the healthcare market. The post Market Acceptance: Key Challenges for Health Tech appeared first on MedCity News.
AstraZeneca’s Datroway, an antibody drug conjugate (ADC), is now FDA approved for advanced cases of breast cancer that is HR positive and HER2 negative. Datroway targets TROP2, the same cancer protein addressed by Trodelvy, a Gilead Sciences ADC also approved for breast cancer. The post AstraZeneca, Daiichi Sankyo ADC Lands FDA Approval in Advanced Breast…
Many healthcare executives are applauding the list of additional drugs chosen for the Medicare Drug Price Negotiation Program, while some drug companies are opposing it. The post How Healthcare Leaders Reacted to the 15 Additional Drugs Selected for Medicare Negotiation Program appeared first on MedCity News.
Here are three key trends that pharma leaders and clinical operations teams should monitor this year, along with a checklist of strategic priorities to stay ahead. The post Navigating 2025: Three Key Trends Shaping the Future of Pharma appeared first on MedCity News.
Healthcare providers and vendors are learning the hard way that hackers are relentless and resourceful, constantly adjusting tactics and tools and using new technology, including AI, to launch more sophisticated attacks. The post Healthcare’s Cybersecurity Crisis: Why Today’s Defenses Are Failing Against Evolving Threats appeared first on MedCity News.
While advancements in diagnostics are promising, the need remains for healthcare professionals to take the lead on proactive conversations with patients and their loved ones about the early signs and symptoms of Alzheimer’s disease. The post Transforming Our Collective Approach to Alzheimer’s Disease Care Begins with Early and Accurate Diagnosis appeared first on MedCity News.
It’s tragic that it takes a shooter, aggravated by his back pain and frustrated with the healthcare system, to spark a necessary conversation about healthcare. The post Zero-Sum Game: The Current Healthcare System Is Reaching a Breaking Point appeared first on MedCity News.
AstraZeneca’s Calquence has expanded its FDA approval to include first-line treatment of mantle cell lymphoma. The regulatory decision makes Calquence the first BTK inhibitor approved as an initial treatment for this type of blood cancer. The post FDA Nod Paves Way for AstraZeneca Drug to Become New Standard of Care in Rare Blood Cancer appeared…
Teladoc Health has joined Amazon’s Health Benefits Connector. Other companies offered through the program include Hinge Health, Rula, Talkspace and Omada. The post Amazon Adds Teladoc Health to Health Benefits Program appeared first on MedCity News.